Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases
Cardiovascular diseases (CVDs) are currently the major cause of death and morbidity on a global scale. Thioredoxin-interacting protein (TXNIP) is a marker related to metabolism, oxidation, and inflammation induced in CVDs. The overexpression of TXNIP is closely related to the occurrence and developm...
Saved in:
Published in | Inflammopharmacology Vol. 31; no. 1; pp. 207 - 220 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.02.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0925-4692 1568-5608 1568-5608 |
DOI | 10.1007/s10787-022-01130-8 |
Cover
Abstract | Cardiovascular diseases (CVDs) are currently the major cause of death and morbidity on a global scale. Thioredoxin-interacting protein (TXNIP) is a marker related to metabolism, oxidation, and inflammation induced in CVDs. The overexpression of TXNIP is closely related to the occurrence and development of CVDs. Hence, TXNIP inhibition is critical for reducing the overactivation of its downstream signaling pathway and, as a result, myocardial cell damage. Due to the chemical variety of dietary phytochemicals, they have garnered increased interest for CVDs prevention and therapy. Phytochemicals are a source of medicinal compounds for a variety of conditions, which aids in the development of effective and safe TXNIP-targeting medications. The objective of this article is to find and virtual screen novel safe, effective, and economically viable TXNIP inhibitors from flavonoids, phenols, and alkaloids derived from foods and plants. The results of the docking study revealed that silibinin, rutin, luteolin, baicalin, procyanidin B2, hesperetin, icariin, and tilianin in flavonoids, polydatin, resveratrol, and salidroside in phenols, and neferine in alkaloids had the highest Vina scores, indicating that these compounds are the active chemicals on TXNIP. In particular, silibinin can be utilized as a lead chemical in the process of structural alteration. These dietary phytochemicals may aid in the discovery of lead compounds for the development of innovative TXNIP agents for the treatment of cardiovascular disease. |
---|---|
AbstractList | Cardiovascular diseases (CVDs) are currently the major cause of death and morbidity on a global scale. Thioredoxin-interacting protein (TXNIP) is a marker related to metabolism, oxidation, and inflammation induced in CVDs. The overexpression of TXNIP is closely related to the occurrence and development of CVDs. Hence, TXNIP inhibition is critical for reducing the overactivation of its downstream signaling pathway and, as a result, myocardial cell damage. Due to the chemical variety of dietary phytochemicals, they have garnered increased interest for CVDs prevention and therapy. Phytochemicals are a source of medicinal compounds for a variety of conditions, which aids in the development of effective and safe TXNIP-targeting medications. The objective of this article is to find and virtual screen novel safe, effective, and economically viable TXNIP inhibitors from flavonoids, phenols, and alkaloids derived from foods and plants. The results of the docking study revealed that silibinin, rutin, luteolin, baicalin, procyanidin B2, hesperetin, icariin, and tilianin in flavonoids, polydatin, resveratrol, and salidroside in phenols, and neferine in alkaloids had the highest Vina scores, indicating that these compounds are the active chemicals on TXNIP. In particular, silibinin can be utilized as a lead chemical in the process of structural alteration. These dietary phytochemicals may aid in the discovery of lead compounds for the development of innovative TXNIP agents for the treatment of cardiovascular disease. Cardiovascular diseases (CVDs) are currently the major cause of death and morbidity on a global scale. Thioredoxin-interacting protein (TXNIP) is a marker related to metabolism, oxidation, and inflammation induced in CVDs. The overexpression of TXNIP is closely related to the occurrence and development of CVDs. Hence, TXNIP inhibition is critical for reducing the overactivation of its downstream signaling pathway and, as a result, myocardial cell damage. Due to the chemical variety of dietary phytochemicals, they have garnered increased interest for CVDs prevention and therapy. Phytochemicals are a source of medicinal compounds for a variety of conditions, which aids in the development of effective and safe TXNIP-targeting medications. The objective of this article is to find and virtual screen novel safe, effective, and economically viable TXNIP inhibitors from flavonoids, phenols, and alkaloids derived from foods and plants. The results of the docking study revealed that silibinin, rutin, luteolin, baicalin, procyanidin B2, hesperetin, icariin, and tilianin in flavonoids, polydatin, resveratrol, and salidroside in phenols, and neferine in alkaloids had the highest Vina scores, indicating that these compounds are the active chemicals on TXNIP. In particular, silibinin can be utilized as a lead chemical in the process of structural alteration. These dietary phytochemicals may aid in the discovery of lead compounds for the development of innovative TXNIP agents for the treatment of cardiovascular disease.Cardiovascular diseases (CVDs) are currently the major cause of death and morbidity on a global scale. Thioredoxin-interacting protein (TXNIP) is a marker related to metabolism, oxidation, and inflammation induced in CVDs. The overexpression of TXNIP is closely related to the occurrence and development of CVDs. Hence, TXNIP inhibition is critical for reducing the overactivation of its downstream signaling pathway and, as a result, myocardial cell damage. Due to the chemical variety of dietary phytochemicals, they have garnered increased interest for CVDs prevention and therapy. Phytochemicals are a source of medicinal compounds for a variety of conditions, which aids in the development of effective and safe TXNIP-targeting medications. The objective of this article is to find and virtual screen novel safe, effective, and economically viable TXNIP inhibitors from flavonoids, phenols, and alkaloids derived from foods and plants. The results of the docking study revealed that silibinin, rutin, luteolin, baicalin, procyanidin B2, hesperetin, icariin, and tilianin in flavonoids, polydatin, resveratrol, and salidroside in phenols, and neferine in alkaloids had the highest Vina scores, indicating that these compounds are the active chemicals on TXNIP. In particular, silibinin can be utilized as a lead chemical in the process of structural alteration. These dietary phytochemicals may aid in the discovery of lead compounds for the development of innovative TXNIP agents for the treatment of cardiovascular disease. |
Author | Ma, Yao-yao Hua, Fang Zhao, Xiao-ni Zhou, Peng |
Author_xml | – sequence: 1 givenname: Peng orcidid: 0000-0002-7322-692X surname: Zhou fullname: Zhou, Peng organization: Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine – sequence: 2 givenname: Yao-yao surname: Ma fullname: Ma, Yao-yao organization: Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine – sequence: 3 givenname: Xiao-ni surname: Zhao fullname: Zhao, Xiao-ni organization: Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine – sequence: 4 givenname: Fang surname: Hua fullname: Hua, Fang email: happyhf6941@sina.com organization: School of Pharmacy, Anhui Xinhua University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36609715$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kTFvFDEQhS0URC6BP0CBXIbCYHtvbW-JIgiRIkgRJDprzp69c7RrH7YXEX59HC5pKFJ5iu-98bx3Qo5iikjIW8E_CM71xyK4NppxKRkXouPMvCAr0SvDesXNEVnxQfZsrQZ5TE5KueWcK62GV-S4U4oPWvQr8vd6d1eT2-EcHEyFQqH7VDHWABOtkLdYaYq07kLK6NOfEFmIFTO4GuKW7nODQ6RnNz-_XV6_p2PKjUVaM0Kdmw1NI3WQfUi_obhlgkx9KAgFy2vycmwr8c3je0p-fPl8c_6VXX2_uDz_dMVct9aVmV6vPSJwMfqNBz4OMDoYNu2YXg9O8I3wvF93BjoE02YvnRJSOj06BQN2p-Ts4Ns--2vBUu0cisNpgohpKVZqJQajWpYNffeILpsZvd3nMEO-s095NcAcAJdTKRlH60KFGlKsGcJkBbcP1dhDNbZVY_9VYx-85X_SJ_dnRd1BVBoct5jtbVpybHE9p7oHUM2jUA |
CitedBy_id | crossref_primary_10_1016_j_ijbiomac_2023_126953 crossref_primary_10_1016_j_carbpol_2024_122728 crossref_primary_10_1016_j_heliyon_2024_e28021 crossref_primary_10_1016_j_intimp_2024_113432 crossref_primary_10_1016_j_intimp_2024_113460 |
Cites_doi | 10.1080/01480545.2019.1687510 10.1155/2019/7670854 10.1007/s11033-018-04575-9 10.1615/JEnvironPatholToxicolOncol.2020032544 10.3390/ijms20133328 10.3390/cells9030678 10.1007/s10735-018-9793-0 10.1155/2018/8597897 10.1016/j.biopha.2022.112655 10.1016/j.ejphar.2020.173389 10.1016/j.bbrc.2021.04.090 10.2174/1567201816666191112113031 10.1016/j.redox.2018.07.002 10.1007/s12035-018-0917-z 10.1002/ptr.7437 10.1142/S0192415X17500057 10.3389/fphar.2017.00692 10.1016/j.fct.2009.03.044 10.3390/nu11050946 10.1038/cddis.2016.139 10.1155/2020/2176728 10.1016/j.intimp.2020.107011 10.7150/ijbs.39259 10.1016/j.intimp.2016.11.018 10.3390/molecules27165083 10.1038/s41577-019-0165-0 10.3389/fphar.2021.706251 10.3390/antiox11010029 10.1007/s11626-020-00434-9 10.1016/j.freeradbiomed.2015.02.029 10.1016/j.intimp.2021.108315 10.1002/brb3.1995 10.1016/j.biopha.2017.10.014 10.3389/fphar.2020.583200 10.2174/0929867323666160106150821 10.1016/j.bbrc.2020.02.147 10.1111/jcmm.16733 10.1016/j.fct.2013.10.045 10.1002/jcp.30456 10.1007/s10753-017-0542-4 10.1016/j.ejmech.2017.03.004 10.1016/j.intimp.2020.106680 10.1111/jfbc.13986 10.3390/antiox11081618 10.1016/j.cyto.2009.11.003 10.1155/2016/1689602 10.1080/21655979.2021.1995994 10.1002/jcb.28480 10.1016/j.abb.2020.108572 10.1016/j.phrs.2018.08.002 10.3390/nu13114070 10.3389/fphar.2018.01180 10.1016/j.phymed.2020.153406 10.1016/j.neulet.2013.06.004 10.1107/S0907444912047099 10.1016/j.gene.2021.145968 10.1016/j.ejphar.2018.10.044 10.1007/s12012-015-9336-9 10.1155/2019/7285434 10.1042/BSR20181043 10.1038/s41401-019-0228-6 10.21037/cdt-19-707 10.3390/antiox10020299 10.1016/j.bbadis.2017.07.030 10.1155/2016/2918796 10.1016/j.jtemb.2020.126704 10.1111/jcmm.12929 10.3390/foods9030374 10.1155/2016/2060874 10.1007/s11418-021-01561-7 10.1016/j.phymed.2017.08.007 10.1155/2022/1652244 10.1155/2019/1243215 10.1002/cbin.11229 10.3389/fphar.2020.00185 10.1016/j.lfs.2015.11.018 10.1007/s11418-018-1241-7 10.1100/2012/708292 10.1093/cvr/cvz152 10.1111/jcmm.14903 10.3390/molecules21030264 10.1186/s12944-017-0449-y 10.3389/fphar.2021.631100 10.1016/j.bcp.2020.114246 10.1016/bs.apha.2019.10.004 10.1111/jfbc.13972 10.1080/13880209.2020.1779318 10.3390/ijms22041693 10.1016/j.phrs.2018.09.021 10.3389/fphar.2021.735087 10.1016/j.phrs.2017.10.008 10.1159/000497061 10.1016/j.gendis.2020.08.008 10.1161/CIRCRESAHA.120.317104 10.3390/nu13072374 10.1016/j.phymed.2018.10.013 10.1016/j.lfs.2019.116797 10.3389/fphar.2021.808480 10.1016/j.ejphar.2019.03.056 10.1016/j.metabol.2014.11.008 10.3389/fphar.2021.771793 10.1002/prp2.728 10.1016/j.phymed.2021.153586 10.1080/13880209.2021.1979052 10.1016/j.phymed.2020.153454 10.1016/j.resp.2021.103707 10.1007/s11033-012-1923-2 10.3390/ijms20040904 10.1111/jcmm.16329 10.1016/j.biopha.2016.11.134 10.1042/BSR20190229 10.1007/s00441-021-03463-2 10.1016/j.phrs.2020.104894 10.1161/ATVBAHA.110.209643 10.1111/bph.13002 10.1002/jat.3989 10.1007/978-3-319-41334-1_19 10.3389/fphar.2020.00712 10.1016/j.biopha.2016.07.025 10.1016/j.phymed.2022.154123 10.1007/s10753-021-01530-y 10.1007/s10787-018-0537-2 10.1016/j.bbrc.2016.07.024 10.1055/s-0035-1545907 10.1016/j.lfs.2020.117887 10.1111/nyas.13386 10.1155/2021/1060271 10.1016/j.biopha.2020.110985 10.1080/13880209.2021.1878236 10.1155/2020/9568647 10.3389/fchem.2019.00697 10.1097/FJC.0000000000000747 10.1097/HJH.0000000000001327 10.1016/j.jnutbio.2012.02.009 10.1155/2021/1805147 10.21037/atm-21-4939 10.1007/s10495-016-1225-6 10.1055/a-1301-8648 10.1016/j.foodchem.2021.129975 10.3390/ijms20061305 10.1016/j.tox.2019.04.011 10.1016/j.biopha.2020.110450 10.1007/s10787-020-00714-6 10.1007/s12013-014-0506-3 10.1021/acs.jafc.0c00070 10.1155/2020/9568278 10.1016/j.intimp.2020.106559 10.3892/mmr.2021.11906 10.3892/etm.2017.4729 10.3390/nu12051516 10.1016/j.jsps.2016.04.025 10.1097/FJC.0000000000001000 10.1155/2021/8865762 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1007/s10787-022-01130-8 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1568-5608 |
EndPage | 220 |
ExternalDocumentID | 36609715 10_1007_s10787_022_01130_8 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: Open Fund of State Key Laboratory of Tea Plant Biology and Utilization grantid: SKLTOF20210112 – fundername: Outstanding Youth Scientific Research Project of Anhui Universities grantid: 2022AH030158 – fundername: Natural Science Foundation of the AnHui Higher Education Institutions of China grantid: KJ2021A1167 – fundername: Key Project Foundation of Natural Science Research in Universities of Anhui Province in China grantid: 2022AH050479 |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 36B 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAXJT AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSNA ACUHS ACZOJ ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEVUW AEXYK AFBBN AFEXP AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMFWP AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. B0M BA0 BBWZM BDATZ BGNMA BSONS CAG COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EAP EAS EBLON EBS EIOEI EJD EMB EMK EMOBN EN4 ESBYG EST ESX F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HG5 HG6 HMJXF HRMNR HVGLF HZ~ IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KAT KDC KOV KPH LLZTM M4Y MA- MK0 N2Q NB0 NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P9S PF0 PT4 PT5 QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC TUS U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WK8 YLTOR Z45 Z7U Z87 Z8O Z91 ZMTXR ZOVNA ~8M ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION NPM 7X8 ABRTQ |
ID | FETCH-LOGICAL-c347t-8574deea01fdbda0f9afca9b006579c10b1d05438a3ea81d0d2c6122c7fc6a9e3 |
IEDL.DBID | U2A |
ISSN | 0925-4692 1568-5608 |
IngestDate | Fri Sep 05 13:31:55 EDT 2025 Thu Apr 03 07:02:00 EDT 2025 Thu Apr 24 22:59:51 EDT 2025 Tue Jul 01 00:28:44 EDT 2025 Fri Feb 21 02:44:19 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Phenols Alkaloids Cardiovascular disease TXNIP Flavonoids Molecular docking |
Language | English |
License | 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c347t-8574deea01fdbda0f9afca9b006579c10b1d05438a3ea81d0d2c6122c7fc6a9e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-7322-692X |
PMID | 36609715 |
PQID | 2761986078 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_2761986078 pubmed_primary_36609715 crossref_citationtrail_10_1007_s10787_022_01130_8 crossref_primary_10_1007_s10787_022_01130_8 springer_journals_10_1007_s10787_022_01130_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20230200 2023-02-00 2023-Feb 20230201 |
PublicationDateYYYYMMDD | 2023-02-01 |
PublicationDate_xml | – month: 2 year: 2023 text: 20230200 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Switzerland |
PublicationSubtitle | Experimental and Therapeutic Studies |
PublicationTitle | Inflammopharmacology |
PublicationTitleAbbrev | Inflammopharmacol |
PublicationTitleAlternate | Inflammopharmacology |
PublicationYear | 2023 |
Publisher | Springer International Publishing |
Publisher_xml | – name: Springer International Publishing |
References | Wang (CR124) 2022; 76 Wu (CR126) 2021; 2021 Liu (CR75) 2021; 9 Chen (CR17) 2021; 25 Lian (CR67) 2019; 55 Bai (CR8) 2021; 133 Song, Li, Hou, Wang, Liu (CR106) 2015; 64 Wu (CR127) 2021; 59 Zhu, Wu, Yang, Feng, Xu (CR158) 2022; 2022 Verma (CR111) 2019; 46 Mai (CR82) 2020; 11 Wang (CR122) 2021; 87 Luo (CR79) 2022; 2022 Luo, Shang, Li (CR78) 2017; 8 Rani, Arya (CR99) 2020; 883 Ikeda (CR46) 2013; 549 Wang (CR118) 2019; 422 Rabbani, Xue, Weickert, Thornalley (CR96) 2021; 13 Gao (CR34) 2020; 116 Kumar (CR57) 2021; 10 Nyandwi (CR89) 2020; 182 Akanda (CR2) 2019; 842 Lim (CR68) 2020; 9 Liu, Ling, Xiong, Xu (CR69) 2012; 39 Xu (CR132) 2020; 40 Liu (CR73) 2020; 41 Kong, Huo, Liu, Li, Chen, Jiang (CR55) 2019; 27 Wang (CR112) 2015; 83 Li, Chen, Huang (CR59) 2018; 42 Cheng, Xia, Han, Rong (CR18) 2016; 2016 Huang, Liu, Huang (CR44) 2018; 18 Amin (CR4) 2020; 256 Wu (CR125) 2020; 84 Liu, Chen, Deng, Lv, Liu (CR70) 2017; 1403 Wang (CR117) 2018; 38 Ni, Li, Xu, Guo (CR88) 2021; 82 Wang (CR119) 2020; 9 Ye, Zhang, Yan, Lin (CR143) 2019; 39 Kuppan (CR58) 2010; 49 Buwa, Mahajan, Patil, Goyal (CR11) 2016; 16 Jin (CR50) 2017; 35 Li (CR60) 2018; 9 Naz (CR86) 2019; 235 Xu (CR131) 2020; 129 Zhou, Zhang, Peng (CR157) 2021; 12 Hitl, Kladar, Gavarić, Božin (CR42) 2021; 87 Song (CR107) 2021; 23 Garg (CR36) 2020; 694 Ma (CR80) 2021; 25 Nasoohi, Ismael, Ishrat (CR85) 2018; 55 Jiang (CR49) 2022; 147 Zhao (CR153) 2018; 18 Cai (CR12) 2021; 12 Liu, Luo, Qiao (CR76) 2022; 45 Chen (CR16) 2020; 16 Choi, Lee, Lee (CR20) 2022; 11 Shi (CR104) 2019; 103 Xu (CR136) 2021; 11 Yuan (CR148) 2017; 34 Fu (CR31) 2021; 2021 Liu, Wang, Wang, Li, Ye (CR71) 2019; 2019 Ding (CR26) 2018; 137 Swanson, Deng, Ting (CR109) 2019; 19 Han (CR40) 2021; 385 Yu (CR146) 2019; 2019 Diao (CR23) 2016; 477 Li (CR63) 2020; 24 Prem, Sivakumar, Boovarahan, Kurian (CR91) 2022; 101 Li (CR61) 2019 Yu (CR145) 2017; 43 Wang (CR120) 2020; 525 Zhao, Zhou, Zhu, Fu, Yu (CR154) 2020; 85 Yuan (CR149) 2020; 28 Dyck, Raj, Zieroth, Dyck, Ezekowitz (CR29) 2019; 20 Gao (CR35) 2021; 2021 Ashrafizadeh, Ahmadi, Mohammadinejad, Farkhondeh, Samarghandian (CR7) 2020; 17 Polekhina (CR90) 2013; 69 Yang (CR140) 2019; 44 Xin (CR129) 2020; 11 Yan, Hu, Hou, Ci, Peng (CR138) 2022 Kim, Seo, Yokoyama (CR53) 2020; 68 Pulido-Moran, Moreno-Fernandez, Ramirez-Tortosa, Ramirez-Tortosa (CR92) 2016; 21 Huang, Xu, Chen, Yue, Tang (CR45) 2021; 11 Imran (CR47) 2017; 16 Li, Chen, Xiao (CR62) 2020; 56 Zeng, Jin, Zhang, Zhang, Liang (CR150) 2018; 135 Quan (CR95) 2021; 59 An (CR5) 2020; 12 Ramezani-Aliakbari, Badavi, Dianat, Mard, Ahangarpour (CR98) 2017; 96 Batiha (CR9) 2020; 9 Bharathi Priya, Huang, Hu, Balasubramanian, Baskaran (CR10) 2021; 45 Li (CR65) 2021; 12 Li, Zhang, Fu (CR64) 2021; 9 Ding (CR25) 2017; 45 Velusamy (CR110) 2020; 2020 Wu (CR128) 2021; 12 Grynkiewicz, Demchuk (CR37) 2019; 7 Altun, Budak (CR3) 2021; 64 Anestopoulos (CR6) 2013; 24 Chen (CR14) 2012; 2012 Kelley, Jeltema, Duan, He (CR52) 2019; 20 Chen (CR15) 2019; 73 Komici (CR54) 2020; 2020 Lu (CR77) 2022; 27 Xu, Li, Song (CR133) 2020; 58 Jeong (CR48) 2009; 47 Wang, Wu, Sui, Wang, Qiu (CR116) 2017; 86 Wang (CR113) 2016; 20 Yao (CR142) 2021; 44 Wang, Li, Jin, Li, Li (CR115) 2017; 14 Caselli, Cirri, Santi, Paoli (CR13) 2016; 23 Machado Dutra, Espitia, Andrade Batista (CR81) 2021; 359 Diao (CR22) 2014; 63 Dinda (CR24) 2017; 131 Ganeshpurkar, Saluja (CR32) 2017; 25 Han (CR39) 2021; 236 Kang (CR51) 2019; 2019 Yang, Xiong, Zou, Wang, Huang (CR139) 2018; 49 Qin (CR94) 2015; 172 Sun (CR108) 2020; 2020 Qi, Wang, Liao, Xue, Wang (CR93) 2021; 12 He, Wang, Shi (CR41) 2020; 87 Zheng (CR155) 2018; 2018 Gao (CR33) 2015; 81 Malaguarnera (CR83) 2019; 11 Nabavi (CR84) 2018; 128 Domingues (CR27) 2021; 22 Xu (CR134) 2021; 12 Zhang (CR152) 2020; 39 Scicchitano (CR102) 2021; 13 Liu, Zhang, Li, Lu (CR72) 2019; 854 Huang (CR43) 2016; 2016 Coelho (CR21) 2017; 1863 Hall (CR38) 2016; 7 Xu, Jiang, Wei, Zhu (CR130) 2018; 18 Wang (CR123) 2021; 88 Choe, Kim (CR19) 2017; 40 Li, Tan, Ouyang, He, Liu (CR66) 2022; 808 Salehi (CR101) 2019; 20 Sahu (CR100) 2016; 144 Feng (CR30) 2016; 21 Yang (CR141) 2021; 77 Yu (CR147) 2020; 10 Dunn, Buckle, Cooke, Ng (CR28) 2010; 30 Wang, Zhao, Zhang, Chen (CR114) 2016; 83 Abplanalp (CR1) 2021; 128 Yamagata, Hashiguchi, Yamamoto, Tagami (CR137) 2019; 74 Wang (CR121) 2021; 101 Nazari-Khanamiri, Ghasemnejad-Berenji (CR87) 2021; 45 Sharma, Gupta, Chauhan, Nair, Sharma (CR103) 2020; 158 Xu, Gao, Wang, Yang, Xie (CR135) 2021; 292 Kseibati, Sharawy, Salem (CR56) 2020; 89 Liu (CR74) 2020; 11 Zhou (CR156) 2021; 559 Yu (CR144) 2016; 2016 Rahnavard (CR97) 2019 Zhai (CR151) 2015; 72 Sinha, Ghosh, Sil (CR105) 2016; 928 K Yan (1130_CR138) 2022 YN Shi (1130_CR104) 2019; 103 K Liu (1130_CR71) 2019; 2019 A Sharma (1130_CR103) 2020; 158 XJ Zhao (1130_CR153) 2018; 18 X Kong (1130_CR55) 2019; 27 X Xu (1130_CR132) 2020; 40 G Chen (1130_CR15) 2019; 73 Y Zhu (1130_CR158) 2022; 2022 G Grynkiewicz (1130_CR37) 2019; 7 GJB Dyck (1130_CR29) 2019; 20 J Feng (1130_CR30) 2016; 21 M Hitl (1130_CR42) 2021; 87 Y Han (1130_CR40) 2021; 385 W Wang (1130_CR116) 2017; 86 H Huang (1130_CR43) 2016; 2016 M Pulido-Moran (1130_CR92) 2016; 21 M Ashrafizadeh (1130_CR7) 2020; 17 L Xin (1130_CR129) 2020; 11 Y Zhang (1130_CR152) 2020; 39 FM Amin (1130_CR4) 2020; 256 N Rabbani (1130_CR96) 2021; 13 M Xu (1130_CR133) 2020; 58 H Kim (1130_CR53) 2020; 68 J Song (1130_CR106) 2015; 64 B Li (1130_CR64) 2021; 9 S Sun (1130_CR108) 2020; 2020 F Liu (1130_CR72) 2019; 854 AR Hall (1130_CR38) 2016; 7 S Naz (1130_CR86) 2019; 235 Q Li (1130_CR63) 2020; 24 YH Chen (1130_CR16) 2020; 16 A Domingues (1130_CR27) 2021; 22 B Salehi (1130_CR101) 2019; 20 Z Wang (1130_CR117) 2018; 38 R Wang (1130_CR119) 2020; 9 M Rahnavard (1130_CR97) 2019 L Xu (1130_CR130) 2018; 18 YY Han (1130_CR39) 2021; 236 XL Wu (1130_CR125) 2020; 84 MR Akanda (1130_CR2) 2019; 842 P Li (1130_CR59) 2018; 42 A Ikeda (1130_CR46) 2013; 549 A Ganeshpurkar (1130_CR32) 2017; 25 W Yu (1130_CR147) 2020; 10 C Yang (1130_CR140) 2019; 44 L Huang (1130_CR45) 2021; 11 M Wang (1130_CR114) 2016; 83 J Bai (1130_CR8) 2021; 133 T Luo (1130_CR79) 2022; 2022 GE Batiha (1130_CR9) 2020; 9 SF Nabavi (1130_CR84) 2018; 128 Y Xu (1130_CR135) 2021; 292 Y Cheng (1130_CR18) 2016; 2016 F Ramezani-Aliakbari (1130_CR98) 2017; 96 M Yang (1130_CR139) 2018; 49 YX Zhou (1130_CR157) 2021; 12 XW Chen (1130_CR14) 2012; 2012 XL Li (1130_CR61) 2019 LM Yu (1130_CR146) 2019; 2019 W Li (1130_CR62) 2020; 56 J Machado Dutra (1130_CR81) 2021; 359 M Imran (1130_CR47) 2017; 16 F Nazari-Khanamiri (1130_CR87) 2021; 45 A Caselli (1130_CR13) 2016; 23 J Diao (1130_CR23) 2016; 477 KV Swanson (1130_CR109) 2019; 19 K Sinha (1130_CR105) 2016; 928 R Wang (1130_CR118) 2019; 422 L Malaguarnera (1130_CR83) 2019; 11 J Ni (1130_CR88) 2021; 82 Y Wang (1130_CR124) 2022; 76 G Polekhina (1130_CR90) 2013; 69 M Li (1130_CR60) 2018; 9 Q Lu (1130_CR77) 2022; 27 BD Sahu (1130_CR100) 2016; 144 D Lian (1130_CR67) 2019; 55 M Ding (1130_CR25) 2017; 45 W Wang (1130_CR112) 2015; 83 XQ Ding (1130_CR26) 2018; 137 W Mai (1130_CR82) 2020; 11 H Gao (1130_CR35) 2021; 2021 Y Liu (1130_CR73) 2020; 41 WT Abplanalp (1130_CR1) 2021; 128 Y Luo (1130_CR78) 2017; 8 JO Lim (1130_CR68) 2020; 9 J Wu (1130_CR126) 2021; 2021 S Nasoohi (1130_CR85) 2018; 55 B Wang (1130_CR115) 2017; 14 DS Wang (1130_CR120) 2020; 525 S Xu (1130_CR134) 2021; 12 J Xu (1130_CR136) 2021; 11 MO Kseibati (1130_CR56) 2020; 89 DQ Song (1130_CR107) 2021; 23 L Jin (1130_CR50) 2017; 35 LL Kang (1130_CR51) 2019; 2019 L Yu (1130_CR144) 2016; 2016 Y Zhou (1130_CR156) 2021; 559 PN Prem (1130_CR91) 2022; 101 L Ma (1130_CR80) 2021; 25 M Kumar (1130_CR57) 2021; 10 JJ Jeong (1130_CR48) 2009; 47 G Kuppan (1130_CR58) 2010; 49 W Liu (1130_CR70) 2017; 1403 Y Xu (1130_CR131) 2020; 129 L Chen (1130_CR17) 2021; 25 M Scicchitano (1130_CR102) 2021; 13 W Yao (1130_CR142) 2021; 44 Z Qi (1130_CR93) 2021; 12 K Yamagata (1130_CR137) 2019; 74 W Zeng (1130_CR150) 2018; 135 S Altun (1130_CR3) 2021; 64 JY Choe (1130_CR19) 2017; 40 Z Liu (1130_CR75) 2021; 9 SS Choi (1130_CR20) 2022; 11 D Liu (1130_CR76) 2022; 45 N Rani (1130_CR99) 2020; 883 Z Huang (1130_CR44) 2018; 18 H Liu (1130_CR74) 2020; 11 I Anestopoulos (1130_CR6) 2013; 24 Z Jiang (1130_CR49) 2022; 147 J Wu (1130_CR128) 2021; 12 C Gao (1130_CR34) 2020; 116 W Qin (1130_CR94) 2015; 172 G Wu (1130_CR127) 2021; 59 Y Cai (1130_CR12) 2021; 12 N Kelley (1130_CR52) 2019; 20 K Komici (1130_CR54) 2020; 2020 B Dinda (1130_CR24) 2017; 131 D Li (1130_CR65) 2021; 12 SW Wang (1130_CR123) 2021; 88 C He (1130_CR41) 2020; 87 AR Coelho (1130_CR21) 2017; 1863 B Yang (1130_CR141) 2021; 77 T Zheng (1130_CR155) 2018; 2018 JB Nyandwi (1130_CR89) 2020; 182 VK Verma (1130_CR111) 2019; 46 XB Wang (1130_CR113) 2016; 20 M Ye (1130_CR143) 2019; 39 Y Yuan (1130_CR148) 2017; 34 H Diao (1130_CR22) 2014; 63 CC Buwa (1130_CR11) 2016; 16 L Bharathi Priya (1130_CR10) 2021; 45 LL Dunn (1130_CR28) 2010; 30 W Quan (1130_CR95) 2021; 59 X Wang (1130_CR122) 2021; 87 M Zhai (1130_CR151) 2015; 72 Y Yuan (1130_CR149) 2020; 28 Y Fu (1130_CR31) 2021; 2021 T Li (1130_CR66) 2022; 808 X Wang (1130_CR121) 2021; 101 X An (1130_CR5) 2020; 12 L Zhao (1130_CR154) 2020; 85 M Liu (1130_CR69) 2012; 39 S Garg (1130_CR36) 2020; 694 Z Yu (1130_CR145) 2017; 43 P Velusamy (1130_CR110) 2020; 2020 Y Gao (1130_CR33) 2015; 81 |
References_xml | – volume: 44 start-page: 601 year: 2021 end-page: 612 ident: CR142 article-title: Toxicological evaluation of a flavonoid, chrysin: morphological, behavioral, biochemical and histopathological assessments in rats publication-title: Drug Chem Toxicol doi: 10.1080/01480545.2019.1687510 – volume: 2019 start-page: 7670854 year: 2019 ident: CR146 article-title: Naringenin attenuates myocardial ischemia-reperfusion injury via cGMP-PKGIα signaling and in vivo and in vitro studies publication-title: Oxid Med Cell Longev doi: 10.1155/2019/7670854 – volume: 46 start-page: 1139 year: 2019 end-page: 1148 ident: CR111 article-title: Role of MAPK/NF-κB pathway in cardioprotective effect of morin in isoproterenol induced myocardial injury in rats publication-title: Mol Biol Rep doi: 10.1007/s11033-018-04575-9 – volume: 39 start-page: 89 year: 2020 end-page: 99 ident: CR152 article-title: Tilianin protects diabetic retina through the modulation of Nrf2/TXNIP/NLRP3 inflammasome pathways publication-title: J Environ Pathol Toxicol Oncol doi: 10.1615/JEnvironPatholToxicolOncol.2020032544 – volume: 20 start-page: 3328 year: 2019 ident: CR52 article-title: The NLRP3 inflammasome: an overview of mechanisms of activation and regulation publication-title: Int J Mol Sci doi: 10.3390/ijms20133328 – volume: 9 start-page: 678 year: 2020 ident: CR68 article-title: Silibinin attenuates silica dioxide nanoparticles-induced inflammation by suppressing TXNIP/MAPKs/AP-1 signaling publication-title: Cells doi: 10.3390/cells9030678 – volume: 49 start-page: 555 year: 2018 end-page: 565 ident: CR139 article-title: Chrysin attenuates interstitial fibrosis and improves cardiac function in a rat model of acute myocardial infarction publication-title: J Mol Histol doi: 10.1007/s10735-018-9793-0 – volume: 2018 start-page: 8597897 year: 2018 ident: CR155 article-title: Salidroside attenuates high-fat diet-induced nonalcoholic fatty liver disease via ampk-dependent TXNIP/NLRP3 pathway publication-title: Oxid Med Cell Longev doi: 10.1155/2018/8597897 – volume: 147 year: 2022 ident: CR49 article-title: Roles and mechanisms of puerarin on cardiovascular disease: a review publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2022.112655 – volume: 883 year: 2020 ident: CR99 article-title: Chrysin rescues rat myocardium from ischemia-reperfusion injury via PPAR-γ/Nrf2 activation publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2020.173389 – volume: 559 start-page: 106 year: 2021 end-page: 112 ident: CR156 article-title: Morin attenuates pyroptosis of nucleus pulposus cells and ameliorates intervertebral disc degeneration via inhibition of the TXNIP/NLRP3/Caspase-1/IL-1β signaling pathway publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2021.04.090 – volume: 17 start-page: 15 year: 2020 end-page: 22 ident: CR7 article-title: Nano-soldiers ameliorate silibinin delivery: a review study publication-title: Curr Drug Deliv doi: 10.2174/1567201816666191112113031 – volume: 18 start-page: 124 year: 2018 end-page: 137 ident: CR153 article-title: Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway publication-title: Redox Biol doi: 10.1016/j.redox.2018.07.002 – volume: 55 start-page: 7900 year: 2018 end-page: 7920 ident: CR85 article-title: Thioredoxin-interacting protein (TXNIP) in cerebrovascular and neurodegenerative diseases: regulation and implication publication-title: Mol Neurobiol doi: 10.1007/s12035-018-0917-z – year: 2022 ident: CR138 article-title: Leonurine inhibits the TXNIP/NLRP3 and NF-κB pathways via Nrf2 activation to alleviate carrageenan-induced pleurisy in mice publication-title: Phytother Res doi: 10.1002/ptr.7437 – volume: 45 start-page: 53 year: 2017 end-page: 66 ident: CR25 article-title: Punicalagin pretreatment attenuates myocardial ischemia-reperfusion injury via activation of AMPK publication-title: Am J Chin Med doi: 10.1142/S0192415X17500057 – volume: 8 start-page: 692 year: 2017 ident: CR78 article-title: Luteolin: a flavonoid that has multiple cardio-protective effects and is molecular mechanisms publication-title: Front Pharmacol doi: 10.3389/fphar.2017.00692 – volume: 47 start-page: 1569 year: 2009 end-page: 1576 ident: CR48 article-title: Rutin from lonicera japonica inhibits myocardial ischemia/reperfusion-induced apoptosis in vivo and protects H9c2 cells against hydrogen peroxide-mediated injury via ERK1/2 and PI3K/Akt signals in vitro publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2009.03.044 – volume: 11 start-page: 946 year: 2019 ident: CR83 article-title: Influence of resveratrol on the immune response publication-title: Nutrients doi: 10.3390/nu11050946 – volume: 7 year: 2016 ident: CR38 article-title: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction publication-title: Cell Death Dis doi: 10.1038/cddis.2016.139 – volume: 2020 start-page: 2176728 year: 2020 ident: CR54 article-title: Cardioprotective effects of dietary phytochemicals on oxidative stress in heart failure by a sex-gender-oriented point of view publication-title: Oxid Med Cell Longev doi: 10.1155/2020/2176728 – volume: 89 year: 2020 ident: CR56 article-title: Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2020.107011 – volume: 16 start-page: 1972 year: 2020 end-page: 1988 ident: CR16 article-title: Protective role of silibinin against myocardial ischemia/reperfusion injury-induced cardiac dysfunction publication-title: Int J Biol Sci doi: 10.7150/ijbs.39259 – volume: 43 start-page: 7 year: 2017 end-page: 15 ident: CR145 article-title: Pterostilbene protects against myocardial ischemia/reperfusion injury via suppressing oxidative/nitrative stress and inflammatory response publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2016.11.018 – volume: 27 start-page: 5083 year: 2022 ident: CR77 article-title: Baicalin alleviate apoptosis via PKC-MAPK pathway in porcine peritoneal mesothelial cells induced by Glaesserella parasuis publication-title: Molecules doi: 10.3390/molecules27165083 – volume: 19 start-page: 477 year: 2019 end-page: 489 ident: CR109 article-title: The NLRP3 inflammasome: molecular activation and regulation to therapeutics publication-title: Nat Rev Immunol doi: 10.1038/s41577-019-0165-0 – volume: 12 year: 2021 ident: CR93 article-title: Neferine ameliorates sepsis-induced myocardial dysfunction through anti-apoptotic and antioxidative effects by regulating the PI3K/AKT/mTOR signaling pathway publication-title: Front Pharmacol doi: 10.3389/fphar.2021.706251 – volume: 11 start-page: 29 year: 2021 ident: CR136 article-title: Punicalagin regulates signaling pathways in inflammation-associated chronic diseases publication-title: Antioxidants doi: 10.3390/antiox11010029 – volume: 56 start-page: 307 year: 2020 end-page: 312 ident: CR62 article-title: Apigenin protects against ischemia-/hypoxia-induced myocardial injury by mediating pyroptosis and apoptosis publication-title: In Vitro Cell Dev Biol Anim doi: 10.1007/s11626-020-00434-9 – volume: 83 start-page: 214 year: 2015 end-page: 226 ident: CR112 article-title: Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2015.02.029 – volume: 101 year: 2021 ident: CR121 article-title: Baicalein alleviates pyroptosis and inflammation in hyperlipidemic pancreatitis by inhibiting NLRP3/Caspase-1 pathway through the miR-192-5p/TXNIP axis publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2021.108315 – volume: 11 year: 2021 ident: CR45 article-title: Leonurine, a potential drug for the treatment of cardiovascular system and central nervous system diseases publication-title: Brain Behav doi: 10.1002/brb3.1995 – volume: 96 start-page: 612 year: 2017 end-page: 618 ident: CR98 article-title: Effects of gallic acid on hemodynamic parameters and infarct size after ischemia-reperfusion in isolated rat hearts with alloxan-induced diabetes publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2017.10.014 – volume: 11 year: 2020 ident: CR129 article-title: Regulatory mechanisms of baicalin in cardiovascular diseases: a review publication-title: Front Pharmacol doi: 10.3389/fphar.2020.583200 – volume: 23 start-page: 774 year: 2016 end-page: 791 ident: CR13 article-title: Morin: a promising natural drug publication-title: Curr Med Chem doi: 10.2174/0929867323666160106150821 – volume: 525 start-page: 759 year: 2020 end-page: 766 ident: CR120 article-title: Formononetin ameliorates myocardial ischemia/reperfusion injury in rats by suppressing the ROS-TXNIP-NLRP3 pathway publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2020.02.147 – volume: 25 start-page: 8015 year: 2021 end-page: 8027 ident: CR80 article-title: Procyanidin B2 alleviates liver injury caused by cold stimulation through sonic hedgehog signalling and autophagy publication-title: J Cell Mol Med doi: 10.1111/jcmm.16733 – volume: 63 start-page: 104 year: 2014 end-page: 110 ident: CR22 article-title: Astilbin protects diabetic rat heart against ischemia-reperfusion injury via blockade of HMGB1-dependent NF-κB signaling pathway publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2013.10.045 – volume: 236 start-page: 7734 year: 2021 end-page: 7744 ident: CR39 article-title: Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP publication-title: J Cell Physiol doi: 10.1002/jcp.30456 – volume: 40 start-page: 980 year: 2017 end-page: 994 ident: CR19 article-title: Quercetin and ascorbic acid suppress fructose-induced NLRP3 inflammasome activation by blocking intracellular shuttling of TXNIP in human macrophage cell lines publication-title: Inflammation doi: 10.1007/s10753-017-0542-4 – volume: 131 start-page: 68 year: 2017 end-page: 80 ident: CR24 article-title: Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2017.03.004 – volume: 85 year: 2020 ident: CR154 article-title: Luteolin alleviates myocardial ischemia reperfusion injury in rats via Siti1/NLRP3/NF-κB pathway publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2020.106680 – volume: 45 year: 2021 ident: CR10 article-title: An updated review on pharmacological properties of neferine-A bisbenzylisoquinoline alkaloid from nelumbo nucifera publication-title: J Food Biochem doi: 10.1111/jfbc.13986 – volume: 11 start-page: 1618 year: 2022 ident: CR20 article-title: A comparative study of hesperetin, hesperidin and hesperidin glucoside: antioxidant, anti-inflammatory, and antibacterial activities in vitro publication-title: Antioxidants (basel) doi: 10.3390/antiox11081618 – volume: 49 start-page: 229 year: 2010 end-page: 234 ident: CR58 article-title: Transcriptional regulation of cytokines and oxidative stress by gallic acid in human THP-1 monocytes publication-title: Cytokine doi: 10.1016/j.cyto.2009.11.003 – volume: 2021 start-page: 8865762 year: 2021 ident: CR126 article-title: Baicalin improves cardiac outcome and survival by suppressing Drp1-mediated mitochondrial fission after cardiac arrest-induced myocardial damage publication-title: Oxid Med Cell Longev – volume: 2016 start-page: 1689602 year: 2016 ident: CR144 article-title: Berberine attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation response: role of silent information regulator 1 publication-title: Oxid Med Cell Longev doi: 10.1155/2016/1689602 – volume: 12 start-page: 10924 year: 2021 end-page: 10934 ident: CR134 article-title: Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis publication-title: Bioengineered doi: 10.1080/21655979.2021.1995994 – year: 2019 ident: CR97 article-title: Curcumin ameliorated myocardial infarction by inhibition of cardiotoxicity in the rat model publication-title: J Cell Biochem doi: 10.1002/jcb.28480 – volume: 694 year: 2020 ident: CR36 article-title: The molecular mechanism involved in cardioprotection by the dietary flavonoid fisetin as an agonist of PPAR-γ in a murine model of myocardial infarction publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2020.108572 – volume: 135 start-page: 122 year: 2018 end-page: 126 ident: CR150 article-title: Naringenin as a potential immunomodulator in therapeutics publication-title: Pharmacol Res doi: 10.1016/j.phrs.2018.08.002 – volume: 13 start-page: 4070 year: 2021 ident: CR102 article-title: Icariin protects H9c2 rat cardiomyoblasts from doxorubicin-induced cardiotoxicity: role of caveolin-1 upregulation and enhanced autophagic response publication-title: Nutrients doi: 10.3390/nu13114070 – volume: 9 start-page: 1180 year: 2018 ident: CR60 article-title: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes publication-title: Front Pharmacol doi: 10.3389/fphar.2018.01180 – volume: 82 year: 2021 ident: CR88 article-title: Salidroside protects against cardiomyocyte apoptosis and ventricular remodeling by AKT/HO-1 signaling pathways in a diabetic cardiomyopathy mouse model publication-title: Phytomedicine doi: 10.1016/j.phymed.2020.153406 – volume: 549 start-page: 135 year: 2013 end-page: 139 ident: CR46 article-title: Suppressive effect of nobiletin, a citrus polymethoxyflavonoid that downregulates thioredoxin-interacting protein expression, on tunicamycin-induced apoptosis in SK-N-SH human neuroblastoma cells publication-title: Neurosci Lett doi: 10.1016/j.neulet.2013.06.004 – volume: 69 start-page: 333 year: 2013 end-page: 344 ident: CR90 article-title: Structure of the N-terminal domain of human thioredoxin-interacting protein publication-title: Acta Crystallogr D Biol Crystallogr doi: 10.1107/S0907444912047099 – volume: 808 year: 2022 ident: CR66 article-title: Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis publication-title: Gene doi: 10.1016/j.gene.2021.145968 – volume: 842 start-page: 291 year: 2019 end-page: 297 ident: CR2 article-title: The biological and pharmacological roles of polyphenol flavonoid tilianin publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2018.10.044 – volume: 16 start-page: 286 year: 2016 end-page: 297 ident: CR11 article-title: Apigenin attenuates β-receptor-stimulated myocardial injury via safeguarding cardiac functions and escalation of antioxidant defence system publication-title: Cardiovasc Toxicol doi: 10.1007/s12012-015-9336-9 – volume: 2019 start-page: 7285434 year: 2019 ident: CR71 article-title: Mangiferin attenuates myocardial ischemia-reperfusion injury via MAPK/Nrf-2/HO-1/NF-κB in vitro and in vivo publication-title: Oxid Med Cell Longev doi: 10.1155/2019/7285434 – volume: 38 start-page: BSR0181043 year: 2018 ident: CR117 article-title: Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway publication-title: Biosci Rep doi: 10.1042/BSR20181043 – volume: 41 start-page: 138 year: 2020 end-page: 144 ident: CR73 article-title: CB-dock: a web server for cavity detection-guided protein-ligand blind docking publication-title: Acta Pharmacol Sin doi: 10.1038/s41401-019-0228-6 – volume: 10 start-page: 752 year: 2020 end-page: 769 ident: CR147 article-title: Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner publication-title: Cardiovasc Diagn Ther doi: 10.21037/cdt-19-707 – volume: 10 start-page: 299 year: 2021 ident: CR57 article-title: Mango ( L.) leaves: nutritional composition, phytochemical profile, and health-promoting bioactivities publication-title: Antioxidants (basel) doi: 10.3390/antiox10020299 – volume: 1863 start-page: 2904 year: 2017 end-page: 2923 ident: CR21 article-title: Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts publication-title: Biochim Biophys Acta Mol Basis Dis doi: 10.1016/j.bbadis.2017.07.030 – volume: 2016 start-page: 2918796 year: 2016 ident: CR43 article-title: The multifunctional effects of nobiletin and its metabolites in vivo and in vitro publication-title: Evid Based Complement Alternat Med doi: 10.1155/2016/2918796 – volume: 64 year: 2021 ident: CR3 article-title: The protective effect of the cardiac thioredoxin system on the heart in the case of iron overload in mice publication-title: J Trace Elem Med Biol doi: 10.1016/j.jtemb.2020.126704 – volume: 20 start-page: 2362 year: 2016 end-page: 2373 ident: CR113 article-title: Associations of polymorphisms in TXNIP and gene-environment interactions with the risk of coronary artery disease in a Chinese Han population publication-title: J Cell Mol Med doi: 10.1111/jcmm.12929 – volume: 9 start-page: 374 year: 2020 ident: CR9 article-title: The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin publication-title: Foods doi: 10.3390/foods9030374 – volume: 2016 start-page: 2060874 year: 2016 ident: CR18 article-title: Plant natural product formononetin protects rat cardiomyocyte H9c2 cells against oxygen glucose deprivation and reoxygenation via inhibiting ROS formation and promoting GSK-3β phosphorylation publication-title: Oxid Med Cell Longev doi: 10.1155/2016/2060874 – volume: 76 start-page: 119 year: 2022 end-page: 131 ident: CR124 article-title: Apigenin exerts chemopreventive effects on lung injury induced by SiO2 nanoparticles through the activation of Nrf2 publication-title: J Nat Med doi: 10.1007/s11418-021-01561-7 – volume: 34 start-page: 106 year: 2017 end-page: 114 ident: CR148 article-title: Tilianin pretreatment prevents myocardial ischemia-reperfusion injury via preservation of mitochondrial function in rat heart publication-title: Phytomedicine doi: 10.1016/j.phymed.2017.08.007 – volume: 2022 start-page: 1652244 year: 2022 ident: CR79 article-title: Corilagin restrains NLRP3 inflammasome activation and pyroptosis through the ROS/TXNIP/NLRP3 pathway to prevent inflammation publication-title: Oxid Med Cell Longev doi: 10.1155/2022/1652244 – volume: 2019 start-page: 1243215 year: 2019 ident: CR51 article-title: Pterostilbene attenuates fructose-induced myocardial fibrosis by inhibiting ROS-driven Pitx2c/miR-15b pathway publication-title: Oxid Med Cell Longev doi: 10.1155/2019/1243215 – year: 2019 ident: CR61 article-title: The protective effects of grape seed procyanidin B2 against asporin mediates glycated low-density lipoprotein induced-cardiomyocyte apoptosis and fibrosis publication-title: Cell Biol Int doi: 10.1002/cbin.11229 – volume: 11 start-page: 185 year: 2020 ident: CR82 article-title: Berberine inhibits nod-like receptor family pyrin domain containing 3 inflammasome activation and pyroptosis in nonalcoholic steatohepatitis via the ROS/TXNIP axis publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00185 – volume: 144 start-page: 8 year: 2016 end-page: 18 ident: CR100 article-title: Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice publication-title: Life Sci doi: 10.1016/j.lfs.2015.11.018 – volume: 73 start-page: 85 year: 2019 end-page: 92 ident: CR15 article-title: Polydatin protects against acute myocardial infarction-induced cardiac damage by activation of Nrf2/HO-1 signaling publication-title: J Nat Med doi: 10.1007/s11418-018-1241-7 – volume: 2012 year: 2012 ident: CR14 article-title: Interaction of herbal compounds with biological targets: a case study with berberine publication-title: Scientific World J doi: 10.1100/2012/708292 – volume: 116 start-page: 645 year: 2020 end-page: 657 ident: CR34 article-title: TXNIP/Redd1 signalling and excessive autophagy: a novel mechanism of myocardial ischaemia/reperfusion injury in mice publication-title: Cardiovasc Res doi: 10.1093/cvr/cvz152 – volume: 24 start-page: 2040 year: 2020 end-page: 2051 ident: CR63 article-title: Baicalein inhibits mitochondrial apoptosis induced by oxidative stress in cardiomyocytes by stabilizing MARCH5 expression publication-title: J Cell Mol Med doi: 10.1111/jcmm.14903 – volume: 21 start-page: 264 year: 2016 ident: CR92 article-title: Curcumin and health publication-title: Molecules doi: 10.3390/molecules21030264 – volume: 16 start-page: 84 year: 2017 ident: CR47 article-title: Mangiferin: a natural miracle bioactive compound against lifestyle related disorders publication-title: Lipids Health Dis doi: 10.1186/s12944-017-0449-y – volume: 12 year: 2021 ident: CR12 article-title: A new therapeutic candidate for cardiovascular diseases: Berberine publication-title: Front Pharmacol doi: 10.3389/fphar.2021.631100 – volume: 182 year: 2020 ident: CR89 article-title: Rosmarinic acid inhibits oxLDL-induced inflammasome activation under high-glucose conditions through downregulating the p38-FOXO1-TXNIP pathway publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2020.114246 – volume: 87 start-page: 179 year: 2020 end-page: 203 ident: CR41 article-title: Pharmacological effects of icariin publication-title: Adv Pharmacol doi: 10.1016/bs.apha.2019.10.004 – volume: 45 year: 2021 ident: CR87 article-title: Cellular and molecular mechanisms of genistein in prevention and treatment of diseases: an overview publication-title: J Food Biochem doi: 10.1111/jfbc.13972 – volume: 58 start-page: 655 year: 2020 end-page: 663 ident: CR133 article-title: Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway publication-title: Pharm Biol doi: 10.1080/13880209.2020.1779318 – volume: 22 start-page: 1693 year: 2021 ident: CR27 article-title: The emerging role of TXNIP in ischemic and cardiovascular diseases; a novel marker and therapeutic target publication-title: Int J Mol Sci doi: 10.3390/ijms22041693 – volume: 137 start-page: 64 year: 2018 end-page: 75 ident: CR26 article-title: Curcumin and allopurinol ameliorate fructose-induced hepatic inflammation in rats via miR-200a-mediated TXNIP/NLRP3 inflammasome inhibition publication-title: Pharmacol Res doi: 10.1016/j.phrs.2018.09.021 – volume: 12 year: 2021 ident: CR128 article-title: Hesperetin exhibits anti-inflammatory effects on chondrocytes via the AMPK pathway to attenuate anterior cruciate ligament transection-induced osteoarthritis publication-title: Front Pharmacol doi: 10.3389/fphar.2021.735087 – volume: 42 start-page: 237 year: 2018 end-page: 247 ident: CR59 article-title: Fisetin administration improves LPS-induced acute otitis media in mouse in vivo publication-title: Int J Mol Med – volume: 128 start-page: 359 year: 2018 end-page: 365 ident: CR84 article-title: Apigenin as neuroprotective agent: of mice and men publication-title: Pharmacol Res doi: 10.1016/j.phrs.2017.10.008 – volume: 103 start-page: 282 year: 2019 end-page: 290 ident: CR104 article-title: Genistein protects H9c2 cardiomyocytes against chemical hypoxia-induced injury via inhibition of apoptosis publication-title: Pharmacology doi: 10.1159/000497061 – volume: 9 start-page: 753 year: 2020 end-page: 765 ident: CR119 article-title: Role of thioredoxin-interacting protein in mediating endothelial dysfunction in hypertension publication-title: Genes Dis doi: 10.1016/j.gendis.2020.08.008 – volume: 128 start-page: 216 year: 2021 end-page: 228 ident: CR1 article-title: Clonal hematopoiesis-driver DNMT3A mutations alter immune cells in heart failure publication-title: Circ Res doi: 10.1161/CIRCRESAHA.120.317104 – volume: 13 start-page: 2374 year: 2021 ident: CR96 article-title: Reversal of insulin resistance in overweight and obese subjects by trans-resveratrol and hesperetin combination-link to dysglycemia, blood pressure, dyslipidemia, and low-grade inflammation publication-title: Nutrients doi: 10.3390/nu13072374 – volume: 55 start-page: 310 year: 2019 end-page: 319 ident: CR67 article-title: Puerarin inhibits hyperglycemia-induced inter-endothelial junction through suppressing endothelial Nlrp3 inflammasome activation via ROS-dependent oxidative pathway publication-title: Phytomedicine doi: 10.1016/j.phymed.2018.10.013 – volume: 235 year: 2019 ident: CR86 article-title: Chrysin: pharmacological and therapeutic properties publication-title: Life Sci doi: 10.1016/j.lfs.2019.116797 – volume: 12 year: 2021 ident: CR65 article-title: Fisetin attenuates doxorubicin-induced cardiomyopathy in vivo and in vitro by inhibiting ferroptosis through SIRT1/Nrf2 signaling pathway activation publication-title: Front Pharmacol doi: 10.3389/fphar.2021.808480 – volume: 854 start-page: 48 year: 2019 end-page: 53 ident: CR72 article-title: Nobiletin suppresses oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2019.03.056 – volume: 44 start-page: 417 year: 2019 end-page: 426 ident: CR140 article-title: Role of TXNIP/NLRP3 in sepsis-induced myocardial dysfunction publication-title: Int J Mol Med – volume: 64 start-page: 428 year: 2015 end-page: 437 ident: CR106 article-title: Mangiferin inhibits endoplasmic reticulum stress-associated thioredoxin-interacting protein/NLRP3 inflammasome activation with regulation of AMPK in endothelial cells publication-title: Metabolism doi: 10.1016/j.metabol.2014.11.008 – volume: 12 year: 2021 ident: CR157 article-title: Effects of puerarin on the prevention and treatment of cardiovascular diseases publication-title: Front Pharmacol doi: 10.3389/fphar.2021.771793 – volume: 9 year: 2021 ident: CR75 article-title: Nobiletin ameliorates cardiac impairment and alleviates cardiac remodeling after acute myocardial infarction in rats via JNK regulation publication-title: Pharmacol Res Perspect doi: 10.1002/prp2.728 – volume: 87 year: 2021 ident: CR122 article-title: Luteolin ameliorates LPS-induced acute liver injury by inhibiting TXNIP-NLRP3 inflammasome in mice publication-title: Phytomedicine doi: 10.1016/j.phymed.2021.153586 – volume: 59 start-page: 1388 year: 2021 end-page: 1401 ident: CR127 article-title: Genistein alleviates H O -induced senescence of human umbilical vein endothelial cells via regulating the TXNIP/NLRP3 axis publication-title: Pharm Biol doi: 10.1080/13880209.2021.1979052 – volume: 88 year: 2021 ident: CR123 article-title: Inhibition of histone acetyltransferase by naringenin and hesperetin suppresses Txnip expression and protects pancreatic β cells in diabetic mice publication-title: Phytomedicine doi: 10.1016/j.phymed.2020.153454 – volume: 292 year: 2021 ident: CR135 article-title: Bakuchiol ameliorates cerebral ischemia-reperfusion injury by modulating NLRP3 inflammasome and Nrf2 signaling publication-title: Respir Physiol Neurobiol doi: 10.1016/j.resp.2021.103707 – volume: 39 start-page: 10439 year: 2012 end-page: 10446 ident: CR69 article-title: Molecular characterization of differentially expressed TXNIP gene and its association with porcine carcass traits publication-title: Mol Biol Rep doi: 10.1007/s11033-012-1923-2 – volume: 77 start-page: 570 year: 2021 end-page: 577 ident: CR141 article-title: Quercetin efficiently alleviates tnf-α-stimulated injury by signal transducer and activator of transcription 1 and mitogen-activated protein kinase pathway in H9c2 cells: a protective role of quercetin in myocarditis publication-title: J Cardiovasc Pharmacol – volume: 20 start-page: 904 year: 2019 ident: CR29 article-title: The effects of resveratrol in patients with cardiovascular disease and heart failure: a narrative review publication-title: Int J Mol Sci doi: 10.3390/ijms20040904 – volume: 25 start-page: 2944 year: 2021 end-page: 2955 ident: CR17 article-title: Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1/FoxO3a pathway publication-title: J Cell Mol Med doi: 10.1111/jcmm.16329 – volume: 86 start-page: 32 year: 2017 end-page: 40 ident: CR116 article-title: Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2016.11.134 – volume: 39 start-page: BSR20190229 year: 2019 ident: CR143 article-title: Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling publication-title: Biosci Rep doi: 10.1042/BSR20190229 – volume: 385 start-page: 739 year: 2021 end-page: 751 ident: CR40 article-title: Puerarin protects cardiomyocytes from ischemia-reperfusion injury by upregulating LncRNA ANRIL and inhibiting autophagy publication-title: Cell Tissue Res doi: 10.1007/s00441-021-03463-2 – volume: 158 year: 2020 ident: CR103 article-title: Astilbin: a promising unexplored compound with multidimensional medicinal and health benefits publication-title: Pharmacol Res doi: 10.1016/j.phrs.2020.104894 – volume: 30 start-page: 2089 year: 2010 end-page: 2098 ident: CR28 article-title: The emerging role of the thioredoxin system in angiogenesis publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.110.209643 – volume: 172 start-page: 5559 year: 2015 end-page: 5572 ident: CR94 article-title: Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice publication-title: Br J Pharmacol doi: 10.1111/bph.13002 – volume: 40 start-page: 1362 year: 2020 end-page: 1372 ident: CR132 article-title: Astilbin ameliorates deoxynivalenol-induced oxidative stress and apoptosis in intestinal porcine epithelial cells (IPEC-J2) publication-title: J Appl Toxicol doi: 10.1002/jat.3989 – volume: 2022 start-page: 7781910 year: 2022 ident: CR158 article-title: Resveratrol inhibits high glucose-induced H9c2 cardiomyocyte hypertrophy and damage via RAGE-dependent inhibition of the NF-κB and TGF-β1/Smad3 pathways publication-title: Evid Based Complement Alternat Med – volume: 928 start-page: 453 year: 2016 end-page: 471 ident: CR105 article-title: Morin and its role in chronic diseases publication-title: Adv Exp Med Biol doi: 10.1007/978-3-319-41334-1_19 – volume: 11 start-page: 712 year: 2020 ident: CR74 article-title: Bakuchiol attenuates oxidative stress and neuron damage by regulating Trx1/TXNIP and the phosphorylation of AMPK after subarachnoid hemorrhage in mice publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00712 – volume: 83 start-page: 975 year: 2016 end-page: 988 ident: CR114 article-title: Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2016.07.025 – volume: 101 year: 2022 ident: CR91 article-title: Recent advances in potential of Fisetin in the management of myocardial ischemia-reperfusion injury-a systematic review publication-title: Phytomedicine doi: 10.1016/j.phymed.2022.154123 – volume: 45 start-page: 88 year: 2022 end-page: 99 ident: CR76 article-title: SHP-1/STAT3 interaction is related to luteolin-induced myocardial ischemia protection publication-title: Inflammation doi: 10.1007/s10753-021-01530-y – volume: 27 start-page: 773 year: 2019 end-page: 780 ident: CR55 article-title: Luteolin suppresses inflammation through inhibiting cAMP-phosphodiesterases activity and expression of adhesion molecules in microvascular endothelial cells publication-title: Inflammopharmacology doi: 10.1007/s10787-018-0537-2 – volume: 477 start-page: 1024 year: 2016 end-page: 1030 ident: CR23 article-title: Rosmarinic acid suppressed high glucose-induced apoptosis in H9c2 cells by ameliorating the mitochondrial function and activating STAT3 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2016.07.024 – volume: 81 start-page: 568 year: 2015 end-page: 577 ident: CR33 article-title: Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats publication-title: Planta Med doi: 10.1055/s-0035-1545907 – volume: 256 year: 2020 ident: CR4 article-title: Dimethyl fumarate ameliorates diabetes-associated vascular complications through ROS-TXNIP-NLRP3 inflammasome pathway publication-title: Life Sci doi: 10.1016/j.lfs.2020.117887 – volume: 1403 start-page: 82 year: 2017 end-page: 91 ident: CR70 article-title: Resveratrol and polydatin as modulators of Ca(2+) mobilization in the cardiovascular system publication-title: Ann N Y Acad Sci doi: 10.1111/nyas.13386 – volume: 2021 start-page: 1060271 year: 2021 ident: CR35 article-title: Insight into the protective effect of salidroside against H O -induced injury in H9C2 cells publication-title: Oxid Med Cell Longev doi: 10.1155/2021/1060271 – volume: 133 year: 2021 ident: CR8 article-title: Gallic acid: pharmacological activities and molecular mechanisms involved in inflammation-related diseases publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.110985 – volume: 59 start-page: 222 year: 2021 end-page: 231 ident: CR95 article-title: Cardioprotective effect of rosmarinic acid against myocardial ischaemia/reperfusion injury via suppression of the NF-κB inflammatory signalling pathway and ROS production in mice publication-title: Pharm Biol doi: 10.1080/13880209.2021.1878236 – volume: 2020 start-page: 9568647 year: 2020 ident: CR108 article-title: Antioxidant effects of salidroside in the cardiovascular system publication-title: Evid Based Complement Alternat Med doi: 10.1155/2020/9568647 – volume: 7 start-page: 697 year: 2019 ident: CR37 article-title: New Perspectives for Fisetin publication-title: Front Chem doi: 10.3389/fchem.2019.00697 – volume: 74 start-page: 558 year: 2019 end-page: 565 ident: CR137 article-title: Dietary apigenin reduces induction of LOX-1 and NLRP3 expression, leukocyte adhesion, and acetylated low-density lipoprotein uptake in human endothelial cells exposed to trimethylamine-N-oxide publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0000000000000747 – volume: 35 start-page: 1502 year: 2017 end-page: 1512 ident: CR50 article-title: Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2 publication-title: J Hypertens doi: 10.1097/HJH.0000000000001327 – volume: 24 start-page: 586 year: 2013 end-page: 594 ident: CR6 article-title: Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms publication-title: J Nutr Biochem doi: 10.1016/j.jnutbio.2012.02.009 – volume: 2021 start-page: 1805147 year: 2021 ident: CR31 article-title: Inhibition of the PERK/TXNIP/NLRP3 axis by baicalin reduces NLRP3 inflammasome-mediated pyroptosis in macrophages infected with mycobacterium tuberculosis publication-title: Mediators Inflamm doi: 10.1155/2021/1805147 – volume: 9 start-page: 1558 year: 2021 ident: CR64 article-title: Anti-inflammatory effects of artesunate on atherosclerosis via miR-16-5p and TXNIP regulation of the NLRP3 inflammasome publication-title: Ann Transl Med doi: 10.21037/atm-21-4939 – volume: 21 start-page: 532 year: 2016 end-page: 545 ident: CR30 article-title: Bakuchiol attenuates c by maintaining mitochondrial function: the role of silent information regulator 1 publication-title: Apoptosis doi: 10.1007/s10495-016-1225-6 – volume: 87 start-page: 273 year: 2021 end-page: 282 ident: CR42 article-title: Rosmarinic acid-human pharmacokinetics and health benefits publication-title: Planta Med doi: 10.1055/a-1301-8648 – volume: 359 year: 2021 ident: CR81 article-title: Formononetin: biological effects and uses - a review publication-title: Food Chem doi: 10.1016/j.foodchem.2021.129975 – volume: 20 start-page: 1305 year: 2019 ident: CR101 article-title: The therapeutic potential of apigenin publication-title: Int J Mol Sci doi: 10.3390/ijms20061305 – volume: 422 start-page: 1 year: 2019 end-page: 13 ident: CR118 article-title: Leonurine alleviates LPS-induced myocarditis through suppressing the NF-кB signaling pathway publication-title: Toxicology doi: 10.1016/j.tox.2019.04.011 – volume: 18 start-page: 1582 year: 2018 end-page: 1590 ident: CR130 article-title: Leonurine protects cardiac function following acute myocardial infarction through anti-apoptosis by the PI3K/AKT/GSK3β signaling pathway publication-title: Mol Med Rep – volume: 129 year: 2020 ident: CR131 article-title: Astilbin combined with lipopolysaccharide induces IL-10-producing regulatory B cells via the STAT3 signalling pathway publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.110450 – volume: 28 start-page: 1327 year: 2020 end-page: 1341 ident: CR149 article-title: Baicalein exerts neuroprotective effect against ischaemic/reperfusion injury via alteration of NF-kB and LOX and AMPK/Nrf2 pathway publication-title: Inflammopharmacology doi: 10.1007/s10787-020-00714-6 – volume: 72 start-page: 589 year: 2015 end-page: 597 ident: CR151 article-title: Icariin acts as a potential agent for preventing cardiac ischemia/reperfusion injury publication-title: Cell Biochem Biophys doi: 10.1007/s12013-014-0506-3 – volume: 68 start-page: 12836 year: 2020 end-page: 12841 ident: CR53 article-title: Chemistry of pterostilbene and its metabolic effects publication-title: J Agric Food Chem doi: 10.1021/acs.jafc.0c00070 – volume: 2020 start-page: 9568278 year: 2020 ident: CR110 article-title: Targeting the Nrf2/ARE signalling pathway to mitigate isoproterenol-induced cardiac hypertrophy: plausible role of hesperetin in redox homeostasis publication-title: Oxid Med Cell Longev doi: 10.1155/2020/9568278 – volume: 84 year: 2020 ident: CR125 article-title: Neferine alleviates memory and cognitive dysfunction in diabetic mice through modulation of the NLRP3 inflammasome pathway and alleviation of endoplasmic-reticulum stress publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2020.106559 – volume: 23 start-page: 267 year: 2021 ident: CR107 article-title: Procyanidin B2 inhibits lipopolysaccharide-induced apoptosis by suppressing the Bcl-2/Bax and NF-κB signalling pathways in human umbilical vein endothelial cells publication-title: Mol Med Rep doi: 10.3892/mmr.2021.11906 – volume: 14 start-page: 2255 year: 2017 end-page: 2260 ident: CR115 article-title: Hesperetin protects against inflammatory response and cardiac fibrosis in postmyocardial infarction mice by inhibiting nuclear factor κB signaling pathway publication-title: Exp Ther Med doi: 10.3892/etm.2017.4729 – volume: 12 start-page: 1516 year: 2020 ident: CR5 article-title: Punicalagin protects diabetic nephropathy by inhibiting pyroptosis based on TXNIP/NLRP3 pathway publication-title: Nutrients doi: 10.3390/nu12051516 – volume: 18 start-page: 4821 year: 2018 end-page: 4830 ident: CR44 article-title: Formononetin may protect aged hearts from ischemia/reperfusion damage by enhancing autophagic degradation publication-title: Mol Med Rep – volume: 25 start-page: 149 year: 2017 end-page: 164 ident: CR32 article-title: The pharmacological potential of rutin publication-title: Saudi Pharm J doi: 10.1016/j.jsps.2016.04.025 – volume: 20 start-page: 904 year: 2019 ident: 1130_CR29 publication-title: Int J Mol Sci doi: 10.3390/ijms20040904 – volume: 46 start-page: 1139 year: 2019 ident: 1130_CR111 publication-title: Mol Biol Rep doi: 10.1007/s11033-018-04575-9 – volume: 47 start-page: 1569 year: 2009 ident: 1130_CR48 publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2009.03.044 – volume: 9 start-page: 1180 year: 2018 ident: 1130_CR60 publication-title: Front Pharmacol doi: 10.3389/fphar.2018.01180 – year: 2019 ident: 1130_CR97 publication-title: J Cell Biochem doi: 10.1002/jcb.28480 – volume: 39 start-page: BSR20190229 year: 2019 ident: 1130_CR143 publication-title: Biosci Rep doi: 10.1042/BSR20190229 – volume: 43 start-page: 7 year: 2017 ident: 1130_CR145 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2016.11.018 – volume: 23 start-page: 267 year: 2021 ident: 1130_CR107 publication-title: Mol Med Rep doi: 10.3892/mmr.2021.11906 – volume: 12 year: 2021 ident: 1130_CR12 publication-title: Front Pharmacol doi: 10.3389/fphar.2021.631100 – volume: 10 start-page: 752 year: 2020 ident: 1130_CR147 publication-title: Cardiovasc Diagn Ther doi: 10.21037/cdt-19-707 – volume: 63 start-page: 104 year: 2014 ident: 1130_CR22 publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2013.10.045 – volume: 1863 start-page: 2904 year: 2017 ident: 1130_CR21 publication-title: Biochim Biophys Acta Mol Basis Dis doi: 10.1016/j.bbadis.2017.07.030 – volume: 45 year: 2021 ident: 1130_CR10 publication-title: J Food Biochem doi: 10.1111/jfbc.13986 – volume: 74 start-page: 558 year: 2019 ident: 1130_CR137 publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0000000000000747 – volume: 87 start-page: 179 year: 2020 ident: 1130_CR41 publication-title: Adv Pharmacol doi: 10.1016/bs.apha.2019.10.004 – volume: 8 start-page: 692 year: 2017 ident: 1130_CR78 publication-title: Front Pharmacol doi: 10.3389/fphar.2017.00692 – volume: 77 start-page: 570 year: 2021 ident: 1130_CR141 publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0000000000001000 – volume: 38 start-page: BSR0181043 year: 2018 ident: 1130_CR117 publication-title: Biosci Rep doi: 10.1042/BSR20181043 – volume: 27 start-page: 773 year: 2019 ident: 1130_CR55 publication-title: Inflammopharmacology doi: 10.1007/s10787-018-0537-2 – volume: 133 year: 2021 ident: 1130_CR8 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.110985 – volume: 83 start-page: 214 year: 2015 ident: 1130_CR112 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2015.02.029 – volume: 30 start-page: 2089 year: 2010 ident: 1130_CR28 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.110.209643 – volume: 2021 start-page: 1060271 year: 2021 ident: 1130_CR35 publication-title: Oxid Med Cell Longev doi: 10.1155/2021/1060271 – volume: 42 start-page: 237 year: 2018 ident: 1130_CR59 publication-title: Int J Mol Med – volume: 128 start-page: 359 year: 2018 ident: 1130_CR84 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2017.10.008 – volume: 87 year: 2021 ident: 1130_CR122 publication-title: Phytomedicine doi: 10.1016/j.phymed.2021.153586 – volume: 2019 start-page: 7670854 year: 2019 ident: 1130_CR146 publication-title: Oxid Med Cell Longev doi: 10.1155/2019/7670854 – volume: 9 start-page: 374 year: 2020 ident: 1130_CR9 publication-title: Foods doi: 10.3390/foods9030374 – volume: 17 start-page: 15 year: 2020 ident: 1130_CR7 publication-title: Curr Drug Deliv doi: 10.2174/1567201816666191112113031 – volume: 2021 start-page: 1805147 year: 2021 ident: 1130_CR31 publication-title: Mediators Inflamm doi: 10.1155/2021/1805147 – volume: 25 start-page: 149 year: 2017 ident: 1130_CR32 publication-title: Saudi Pharm J doi: 10.1016/j.jsps.2016.04.025 – volume: 182 year: 2020 ident: 1130_CR89 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2020.114246 – volume: 10 start-page: 299 year: 2021 ident: 1130_CR57 publication-title: Antioxidants (basel) doi: 10.3390/antiox10020299 – volume: 129 year: 2020 ident: 1130_CR131 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.110450 – volume: 147 year: 2022 ident: 1130_CR49 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2022.112655 – volume: 25 start-page: 2944 year: 2021 ident: 1130_CR17 publication-title: J Cell Mol Med doi: 10.1111/jcmm.16329 – volume: 96 start-page: 612 year: 2017 ident: 1130_CR98 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2017.10.014 – volume: 25 start-page: 8015 year: 2021 ident: 1130_CR80 publication-title: J Cell Mol Med doi: 10.1111/jcmm.16733 – volume: 144 start-page: 8 year: 2016 ident: 1130_CR100 publication-title: Life Sci doi: 10.1016/j.lfs.2015.11.018 – volume: 549 start-page: 135 year: 2013 ident: 1130_CR46 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2013.06.004 – volume: 2019 start-page: 1243215 year: 2019 ident: 1130_CR51 publication-title: Oxid Med Cell Longev doi: 10.1155/2019/1243215 – volume: 477 start-page: 1024 year: 2016 ident: 1130_CR23 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2016.07.024 – volume: 2022 start-page: 1652244 year: 2022 ident: 1130_CR79 publication-title: Oxid Med Cell Longev doi: 10.1155/2022/1652244 – volume: 11 year: 2020 ident: 1130_CR129 publication-title: Front Pharmacol doi: 10.3389/fphar.2020.583200 – volume: 9 year: 2021 ident: 1130_CR75 publication-title: Pharmacol Res Perspect doi: 10.1002/prp2.728 – volume: 76 start-page: 119 year: 2022 ident: 1130_CR124 publication-title: J Nat Med doi: 10.1007/s11418-021-01561-7 – volume: 85 year: 2020 ident: 1130_CR154 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2020.106680 – volume: 40 start-page: 1362 year: 2020 ident: 1130_CR132 publication-title: J Appl Toxicol doi: 10.1002/jat.3989 – volume: 20 start-page: 1305 year: 2019 ident: 1130_CR101 publication-title: Int J Mol Sci doi: 10.3390/ijms20061305 – volume: 2018 start-page: 8597897 year: 2018 ident: 1130_CR155 publication-title: Oxid Med Cell Longev doi: 10.1155/2018/8597897 – volume: 21 start-page: 264 year: 2016 ident: 1130_CR92 publication-title: Molecules doi: 10.3390/molecules21030264 – volume: 422 start-page: 1 year: 2019 ident: 1130_CR118 publication-title: Toxicology doi: 10.1016/j.tox.2019.04.011 – volume: 101 year: 2022 ident: 1130_CR91 publication-title: Phytomedicine doi: 10.1016/j.phymed.2022.154123 – volume: 49 start-page: 229 year: 2010 ident: 1130_CR58 publication-title: Cytokine doi: 10.1016/j.cyto.2009.11.003 – volume: 235 year: 2019 ident: 1130_CR86 publication-title: Life Sci doi: 10.1016/j.lfs.2019.116797 – volume: 7 start-page: 697 year: 2019 ident: 1130_CR37 publication-title: Front Chem doi: 10.3389/fchem.2019.00697 – volume: 34 start-page: 106 year: 2017 ident: 1130_CR148 publication-title: Phytomedicine doi: 10.1016/j.phymed.2017.08.007 – volume: 2016 start-page: 2060874 year: 2016 ident: 1130_CR18 publication-title: Oxid Med Cell Longev doi: 10.1155/2016/2060874 – volume: 12 year: 2021 ident: 1130_CR65 publication-title: Front Pharmacol doi: 10.3389/fphar.2021.808480 – volume: 55 start-page: 310 year: 2019 ident: 1130_CR67 publication-title: Phytomedicine doi: 10.1016/j.phymed.2018.10.013 – volume: 928 start-page: 453 year: 2016 ident: 1130_CR105 publication-title: Adv Exp Med Biol doi: 10.1007/978-3-319-41334-1_19 – volume: 59 start-page: 1388 year: 2021 ident: 1130_CR127 publication-title: Pharm Biol doi: 10.1080/13880209.2021.1979052 – volume: 18 start-page: 4821 year: 2018 ident: 1130_CR44 publication-title: Mol Med Rep – volume: 9 start-page: 678 year: 2020 ident: 1130_CR68 publication-title: Cells doi: 10.3390/cells9030678 – volume: 45 start-page: 88 year: 2022 ident: 1130_CR76 publication-title: Inflammation doi: 10.1007/s10753-021-01530-y – volume: 56 start-page: 307 year: 2020 ident: 1130_CR62 publication-title: In Vitro Cell Dev Biol Anim doi: 10.1007/s11626-020-00434-9 – volume: 385 start-page: 739 year: 2021 ident: 1130_CR40 publication-title: Cell Tissue Res doi: 10.1007/s00441-021-03463-2 – volume: 58 start-page: 655 year: 2020 ident: 1130_CR133 publication-title: Pharm Biol doi: 10.1080/13880209.2020.1779318 – volume: 59 start-page: 222 year: 2021 ident: 1130_CR95 publication-title: Pharm Biol doi: 10.1080/13880209.2021.1878236 – volume: 11 start-page: 946 year: 2019 ident: 1130_CR83 publication-title: Nutrients doi: 10.3390/nu11050946 – volume: 13 start-page: 4070 year: 2021 ident: 1130_CR102 publication-title: Nutrients doi: 10.3390/nu13114070 – volume: 854 start-page: 48 year: 2019 ident: 1130_CR72 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2019.03.056 – volume: 103 start-page: 282 year: 2019 ident: 1130_CR104 publication-title: Pharmacology doi: 10.1159/000497061 – volume: 23 start-page: 774 year: 2016 ident: 1130_CR13 publication-title: Curr Med Chem doi: 10.2174/0929867323666160106150821 – volume: 81 start-page: 568 year: 2015 ident: 1130_CR33 publication-title: Planta Med doi: 10.1055/s-0035-1545907 – volume: 20 start-page: 2362 year: 2016 ident: 1130_CR113 publication-title: J Cell Mol Med doi: 10.1111/jcmm.12929 – volume: 2019 start-page: 7285434 year: 2019 ident: 1130_CR71 publication-title: Oxid Med Cell Longev doi: 10.1155/2019/7285434 – volume: 7 year: 2016 ident: 1130_CR38 publication-title: Cell Death Dis doi: 10.1038/cddis.2016.139 – volume: 49 start-page: 555 year: 2018 ident: 1130_CR139 publication-title: J Mol Histol doi: 10.1007/s10735-018-9793-0 – volume: 64 year: 2021 ident: 1130_CR3 publication-title: J Trace Elem Med Biol doi: 10.1016/j.jtemb.2020.126704 – volume: 16 start-page: 1972 year: 2020 ident: 1130_CR16 publication-title: Int J Biol Sci doi: 10.7150/ijbs.39259 – volume: 11 start-page: 185 year: 2020 ident: 1130_CR82 publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00185 – volume: 135 start-page: 122 year: 2018 ident: 1130_CR150 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2018.08.002 – volume: 19 start-page: 477 year: 2019 ident: 1130_CR109 publication-title: Nat Rev Immunol doi: 10.1038/s41577-019-0165-0 – volume: 101 year: 2021 ident: 1130_CR121 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2021.108315 – volume: 45 start-page: 53 year: 2017 ident: 1130_CR25 publication-title: Am J Chin Med doi: 10.1142/S0192415X17500057 – volume: 256 year: 2020 ident: 1130_CR4 publication-title: Life Sci doi: 10.1016/j.lfs.2020.117887 – volume: 39 start-page: 10439 year: 2012 ident: 1130_CR69 publication-title: Mol Biol Rep doi: 10.1007/s11033-012-1923-2 – volume: 12 start-page: 1516 year: 2020 ident: 1130_CR5 publication-title: Nutrients doi: 10.3390/nu12051516 – volume: 40 start-page: 980 year: 2017 ident: 1130_CR19 publication-title: Inflammation doi: 10.1007/s10753-017-0542-4 – volume: 14 start-page: 2255 year: 2017 ident: 1130_CR115 publication-title: Exp Ther Med doi: 10.3892/etm.2017.4729 – volume: 24 start-page: 586 year: 2013 ident: 1130_CR6 publication-title: J Nutr Biochem doi: 10.1016/j.jnutbio.2012.02.009 – volume: 88 year: 2021 ident: 1130_CR123 publication-title: Phytomedicine doi: 10.1016/j.phymed.2020.153454 – volume: 11 start-page: 1618 year: 2022 ident: 1130_CR20 publication-title: Antioxidants (basel) doi: 10.3390/antiox11081618 – volume: 18 start-page: 1582 year: 2018 ident: 1130_CR130 publication-title: Mol Med Rep – volume: 86 start-page: 32 year: 2017 ident: 1130_CR116 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2016.11.134 – volume: 72 start-page: 589 year: 2015 ident: 1130_CR151 publication-title: Cell Biochem Biophys doi: 10.1007/s12013-014-0506-3 – year: 2019 ident: 1130_CR61 publication-title: Cell Biol Int doi: 10.1002/cbin.11229 – volume: 12 year: 2021 ident: 1130_CR93 publication-title: Front Pharmacol doi: 10.3389/fphar.2021.706251 – volume: 11 year: 2021 ident: 1130_CR45 publication-title: Brain Behav doi: 10.1002/brb3.1995 – volume: 9 start-page: 1558 year: 2021 ident: 1130_CR64 publication-title: Ann Transl Med doi: 10.21037/atm-21-4939 – volume: 45 year: 2021 ident: 1130_CR87 publication-title: J Food Biochem doi: 10.1111/jfbc.13972 – volume: 55 start-page: 7900 year: 2018 ident: 1130_CR85 publication-title: Mol Neurobiol doi: 10.1007/s12035-018-0917-z – volume: 64 start-page: 428 year: 2015 ident: 1130_CR106 publication-title: Metabolism doi: 10.1016/j.metabol.2014.11.008 – volume: 9 start-page: 753 year: 2020 ident: 1130_CR119 publication-title: Genes Dis doi: 10.1016/j.gendis.2020.08.008 – volume: 131 start-page: 68 year: 2017 ident: 1130_CR24 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2017.03.004 – volume: 292 year: 2021 ident: 1130_CR135 publication-title: Respir Physiol Neurobiol doi: 10.1016/j.resp.2021.103707 – volume: 84 year: 2020 ident: 1130_CR125 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2020.106559 – volume: 12 start-page: 10924 year: 2021 ident: 1130_CR134 publication-title: Bioengineered doi: 10.1080/21655979.2021.1995994 – volume: 28 start-page: 1327 year: 2020 ident: 1130_CR149 publication-title: Inflammopharmacology doi: 10.1007/s10787-020-00714-6 – volume: 359 year: 2021 ident: 1130_CR81 publication-title: Food Chem doi: 10.1016/j.foodchem.2021.129975 – volume: 11 start-page: 29 year: 2021 ident: 1130_CR136 publication-title: Antioxidants doi: 10.3390/antiox11010029 – volume: 137 start-page: 64 year: 2018 ident: 1130_CR26 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2018.09.021 – volume: 2022 start-page: 7781910 year: 2022 ident: 1130_CR158 publication-title: Evid Based Complement Alternat Med – volume: 13 start-page: 2374 year: 2021 ident: 1130_CR96 publication-title: Nutrients doi: 10.3390/nu13072374 – volume: 2020 start-page: 9568647 year: 2020 ident: 1130_CR108 publication-title: Evid Based Complement Alternat Med doi: 10.1155/2020/9568647 – volume: 11 start-page: 712 year: 2020 ident: 1130_CR74 publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00712 – volume: 172 start-page: 5559 year: 2015 ident: 1130_CR94 publication-title: Br J Pharmacol doi: 10.1111/bph.13002 – volume: 559 start-page: 106 year: 2021 ident: 1130_CR156 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2021.04.090 – volume: 68 start-page: 12836 year: 2020 ident: 1130_CR53 publication-title: J Agric Food Chem doi: 10.1021/acs.jafc.0c00070 – volume: 35 start-page: 1502 year: 2017 ident: 1130_CR50 publication-title: J Hypertens doi: 10.1097/HJH.0000000000001327 – volume: 694 year: 2020 ident: 1130_CR36 publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2020.108572 – volume: 22 start-page: 1693 year: 2021 ident: 1130_CR27 publication-title: Int J Mol Sci doi: 10.3390/ijms22041693 – volume: 2020 start-page: 9568278 year: 2020 ident: 1130_CR110 publication-title: Oxid Med Cell Longev doi: 10.1155/2020/9568278 – volume: 2016 start-page: 2918796 year: 2016 ident: 1130_CR43 publication-title: Evid Based Complement Alternat Med doi: 10.1155/2016/2918796 – volume: 842 start-page: 291 year: 2019 ident: 1130_CR2 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2018.10.044 – volume: 158 year: 2020 ident: 1130_CR103 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2020.104894 – volume: 525 start-page: 759 year: 2020 ident: 1130_CR120 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2020.02.147 – volume: 83 start-page: 975 year: 2016 ident: 1130_CR114 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2016.07.025 – volume: 69 start-page: 333 year: 2013 ident: 1130_CR90 publication-title: Acta Crystallogr D Biol Crystallogr doi: 10.1107/S0907444912047099 – volume: 24 start-page: 2040 year: 2020 ident: 1130_CR63 publication-title: J Cell Mol Med doi: 10.1111/jcmm.14903 – volume: 73 start-page: 85 year: 2019 ident: 1130_CR15 publication-title: J Nat Med doi: 10.1007/s11418-018-1241-7 – volume: 236 start-page: 7734 year: 2021 ident: 1130_CR39 publication-title: J Cell Physiol doi: 10.1002/jcp.30456 – volume: 87 start-page: 273 year: 2021 ident: 1130_CR42 publication-title: Planta Med doi: 10.1055/a-1301-8648 – volume: 39 start-page: 89 year: 2020 ident: 1130_CR152 publication-title: J Environ Pathol Toxicol Oncol doi: 10.1615/JEnvironPatholToxicolOncol.2020032544 – volume: 883 year: 2020 ident: 1130_CR99 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2020.173389 – volume: 12 year: 2021 ident: 1130_CR157 publication-title: Front Pharmacol doi: 10.3389/fphar.2021.771793 – volume: 41 start-page: 138 year: 2020 ident: 1130_CR73 publication-title: Acta Pharmacol Sin doi: 10.1038/s41401-019-0228-6 – volume: 2021 start-page: 8865762 year: 2021 ident: 1130_CR126 publication-title: Oxid Med Cell Longev doi: 10.1155/2021/8865762 – volume: 44 start-page: 601 year: 2021 ident: 1130_CR142 publication-title: Drug Chem Toxicol doi: 10.1080/01480545.2019.1687510 – volume: 89 year: 2020 ident: 1130_CR56 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2020.107011 – volume: 44 start-page: 417 year: 2019 ident: 1130_CR140 publication-title: Int J Mol Med – volume: 2012 year: 2012 ident: 1130_CR14 publication-title: Scientific World J doi: 10.1100/2012/708292 – volume: 116 start-page: 645 year: 2020 ident: 1130_CR34 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvz152 – volume: 2020 start-page: 2176728 year: 2020 ident: 1130_CR54 publication-title: Oxid Med Cell Longev doi: 10.1155/2020/2176728 – volume: 27 start-page: 5083 year: 2022 ident: 1130_CR77 publication-title: Molecules doi: 10.3390/molecules27165083 – volume: 21 start-page: 532 year: 2016 ident: 1130_CR30 publication-title: Apoptosis doi: 10.1007/s10495-016-1225-6 – volume: 808 year: 2022 ident: 1130_CR66 publication-title: Gene doi: 10.1016/j.gene.2021.145968 – volume: 18 start-page: 124 year: 2018 ident: 1130_CR153 publication-title: Redox Biol doi: 10.1016/j.redox.2018.07.002 – volume: 2016 start-page: 1689602 year: 2016 ident: 1130_CR144 publication-title: Oxid Med Cell Longev doi: 10.1155/2016/1689602 – volume: 16 start-page: 286 year: 2016 ident: 1130_CR11 publication-title: Cardiovasc Toxicol doi: 10.1007/s12012-015-9336-9 – volume: 12 year: 2021 ident: 1130_CR128 publication-title: Front Pharmacol doi: 10.3389/fphar.2021.735087 – volume: 1403 start-page: 82 year: 2017 ident: 1130_CR70 publication-title: Ann N Y Acad Sci doi: 10.1111/nyas.13386 – volume: 16 start-page: 84 year: 2017 ident: 1130_CR47 publication-title: Lipids Health Dis doi: 10.1186/s12944-017-0449-y – volume: 20 start-page: 3328 year: 2019 ident: 1130_CR52 publication-title: Int J Mol Sci doi: 10.3390/ijms20133328 – volume: 82 year: 2021 ident: 1130_CR88 publication-title: Phytomedicine doi: 10.1016/j.phymed.2020.153406 – volume: 128 start-page: 216 year: 2021 ident: 1130_CR1 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.120.317104 – year: 2022 ident: 1130_CR138 publication-title: Phytother Res doi: 10.1002/ptr.7437 |
SSID | ssj0006769 |
Score | 2.3355339 |
SecondaryResourceType | review_article |
Snippet | Cardiovascular diseases (CVDs) are currently the major cause of death and morbidity on a global scale. Thioredoxin-interacting protein (TXNIP) is a marker... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 207 |
SubjectTerms | Allergology Biomedical and Life Sciences Biomedicine Dermatology Gastroenterology Immunology Pharmacology/Toxicology Review Rheumatology |
Title | Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases |
URI | https://link.springer.com/article/10.1007/s10787-022-01130-8 https://www.ncbi.nlm.nih.gov/pubmed/36609715 https://www.proquest.com/docview/2761986078 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8QwEB48QHwRb9eLCCKKG-jd7OMi3ij7sAvrU0mTVBekFVvB9dc702NXUQTf0xT6TZIvnW--ATi0rVgLoRV3g47inlQhj4VvuDSOsaWUdEUgtcV9cDXwbob-sC4Kyxu1e5OSLHfqL8VuGFyc1OcYk67FxSzM--QnhVE8cLqT_ZdEm6XDnuNzvPw5danM73N8P45-cMwf-dHy2LlYhqWaL7JuBfAKzJh0FRbu6oz4Khz1Ku_pcZv1p6VUeZsdsd7UlXq8Bh-9p3FB7bFKf4CcyZy9ZAVphXD6Sg_OspQVT6OMPETfRyknK4myiCp9ZKWfwyhlx_3h_XXvhCHXxbGGTYTqLEuY-iZuZXXyJ1-HwcV5_-yK140XuHK9sODCDz1tjLTsRMdaWklHJkqSe2Lghx2F-NoaqZ4rpGskEl5LOwqZkqPCRAWyY9wNmEuz1GwBEx7e94QxdqiRSMRSONpVvhJk4mO8WLXAbr5_pGpXcmqO8RxN_ZQJswgxi0rMItGC08kzL5Unx5-jDxpYI1w6lA-Rqcne8sihXzgiwAdasFnhPZnPDQJy1_Jb0G4CIKpXd_7Hy7b_N3wHFql9faUC34W54vXN7CHJKeJ9mO9ePtye75ex_QkeL_Wo |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZSwMxEB60gvoi3tYzgohiA3tv-iii1Kv0oYW-hWyS1YLsirsF6683s0erKILvOWBnknyz8803ACe2FSnGlKRu0JbUEzKkEfM1FdrRthACQwRkW3SDzsC7G_rDqigsq9nudUqyuKm_FLsZ56LIPjc-6VqUzcMCphkx5Bo4l9P7F0mbhcKe41MT_DlVqczva3x_jn5gzB_50eLZuVmFlQovksvSwGswp5N1WHysMuLrcNortacnLdKflVJlLXJKejNV6skGfPSeJzm2xyr0ATIiMvKa5sgVMsuXfHCSJiR_HqWoIfo-SihKSRRFVMkTKfQcRgk56w-7t71zYrCuGavJlKhO0pjIb-RWUiV_sk0Y3Fz3rzq0arxApeuFOWV-6CmthWXHKlLCitsilgLVEwM_bEtjX1sZqOcy4WphAK-lHGmQkiPDWAaird0taCRponeAMM_Ee0xrO1QGSESCOcqVvmQo4qO9SDbBrr8_l5UqOTbHeOEzPWW0GTc244XNOGvCxXTOa6nJ8efo49qs3BwdzIeIRKfjjDv4C4cFZkITtkt7T9dzgwDVtfwmtGoH4NXpzv7YbPd_w49gqdN_fOAPt937PVjGVvYlI3wfGvnbWB8YwJNHh4V_fwL0z_b3 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1dTxQxFL3BJSG-oKLAqmhJDNGwhfme7iMBFhDdzMOSrE9Np-3ARtPZOLOJy6-3dz52QQyJ8b3tdDqn7encc08BPrhOqhhTkvpRX9JAyJimLNRUaE-7Qgg8IqDaYhidXwWfx-H4ThZ_pXZvQ5J1TgO6NJnycKqywzuJbxZoFJXoFp--Q9kTWA3wDokOrB6dfbs8XazGKOGs_Pa8kNqjoNckzvy9lfub0wPG-SBaWm1Cg2cg2u7X2pPvB7MyPZC3fzg7_s_7PYf1hqGSoxpSL2BFmw1Y-9rE4DdgL6ndruc9MlombxU9skeSpQ_2_CXcJjfzEi_kqhwJCiIKMs2xExbypFagk9yQ8maSo2vpr4mhaF5RpW2Za1I5SEwM-TgaDy-ST8Sya1tWk4U0nuQZkffktKQJNxWv4GpwOjo-p81VD1T6QVxSFsaB0lo4bqZSJZysLzIp0K8xCuO-tIhylSWXPhO-FpZiO8qTlpt5Ms5kJPra34SOyY3eBsICe8JkWruxstQlFcxTvgwlQ9sgHaSyC277jblsfNDxOo4ffOngjKPP7ejzavQ568L-os60dgF5tPRuCx1uJytGYITR-azgHv40YpGt0IWtGlOL9vwoQj-vsAu9Fh-8WU-KRx72-t-Kv4e15GTAv1wML9_AU88ytlqC_hY65c-Z3rEMq0zfNZPoN5elHNo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phytochemicals+as+potential+target+on+thioredoxin-interacting+protein+%28TXNIP%29+for+the+treatment+of+cardiovascular+diseases&rft.jtitle=Inflammopharmacology&rft.au=Zhou%2C+Peng&rft.au=Ma%2C+Yao-Yao&rft.au=Zhao%2C+Xiao-Ni&rft.au=Hua%2C+Fang&rft.date=2023-02-01&rft.eissn=1568-5608&rft.volume=31&rft.issue=1&rft.spage=207&rft_id=info:doi/10.1007%2Fs10787-022-01130-8&rft_id=info%3Apmid%2F36609715&rft.externalDocID=36609715 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0925-4692&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0925-4692&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0925-4692&client=summon |